ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $96,000 | -36.4% | 131,036 | -1.0% | 0.01% | -43.5% |
| Q2 2022 | $151,000 | -51.1% | 132,405 | -12.3% | 0.02% | -43.9% |
| Q1 2022 | $309,000 | -60.4% | 150,914 | -44.3% | 0.04% | -58.2% |
| Q4 2021 | $780,000 | +445.5% | 270,772 | +701.4% | 0.10% | +553.3% |
| Q3 2021 | $143,000 | +6.7% | 33,788 | +52.8% | 0.02% | -6.2% |
| Q4 2019 | $134,000 | -24.3% | 22,106 | +1.9% | 0.02% | +60.0% |
| Q3 2018 | $177,000 | -63.6% | 21,700 | -44.1% | 0.01% | -66.7% |
| Q4 2017 | $486,000 | +162.7% | 38,800 | +256.0% | 0.03% | +150.0% |
| Q2 2017 | $185,000 | -70.1% | 10,900 | -64.6% | 0.01% | -63.6% |
| Q1 2017 | $619,000 | +189.3% | 30,800 | +124.8% | 0.03% | +153.8% |
| Q4 2016 | $214,000 | – | 13,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |